Global Assisted Reproductive Technology (ART) Market Research Report 2023
Global Assisted Reproductive Technology (ART) Market Overview:
Global Assisted Reproductive Technology (ART) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Assisted Reproductive Technology (ART) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Assisted Reproductive Technology (ART) Market
The Assisted Reproductive Technology (ART) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Assisted Reproductive Technology (ART) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Assisted Reproductive Technology (ART) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Assisted Reproductive Technology (ART) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Assisted Reproductive Technology (ART) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Assisted Reproductive Technology (ART) Market Segmentation
Global Assisted Reproductive Technology (ART) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Assisted Reproductive Technology (ART) market has been segmented into:
In-Vitro Fertilization
Artificial Insemination
Others
By Application, Assisted Reproductive Technology (ART) market has been segmented into:
Hospitals
Fertility Clinics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Assisted Reproductive Technology (ART) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Assisted Reproductive Technology (ART) market.
Top Key Players Covered in Assisted Reproductive Technology (ART) market are:
OvaScience
Irvine Scientific
Bloom IVF Centre
Microm Ltd.
CooperSurgical Inc.
Vitrolife
Nidacon International AB
Ferring B.V.
Laboratoire CCD
Hamilton Thorne
Objective to buy this Report:
1. Assisted Reproductive Technology (ART) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Assisted Reproductive Technology (ART) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Global Assisted Reproductive Technology (ART) Market Report 2022 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Assisted Reproductive Technology (ART) involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Assisted Reproductive Technology (ART) Market
The Assisted Reproductive Technology (ART) Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Assisted Reproductive Technology (ART) Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Assisted Reproductive Technology (ART) Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Assisted Reproductive Technology (ART) Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Assisted Reproductive Technology (ART) market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Assisted Reproductive Technology (ART) Market Segmentation
Global Assisted Reproductive Technology (ART) Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Assisted Reproductive Technology (ART) market has been segmented into:
In-Vitro Fertilization
Artificial Insemination
Others
By Application, Assisted Reproductive Technology (ART) market has been segmented into:
Hospitals
Fertility Clinics
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Assisted Reproductive Technology (ART) market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Assisted Reproductive Technology (ART) market.
Top Key Players Covered in Assisted Reproductive Technology (ART) market are:
OvaScience
Irvine Scientific
Bloom IVF Centre
Microm Ltd.
CooperSurgical Inc.
Vitrolife
Nidacon International AB
Ferring B.V.
Laboratoire CCD
Hamilton Thorne
Objective to buy this Report:
1. Assisted Reproductive Technology (ART) analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Assisted Reproductive Technology (ART) market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
CHAPTER 1: INTRODUCTION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TYPE
5.1 Assisted Reproductive Technology (ART) Market Overview Snapshot and Growth Engine
5.2 Assisted Reproductive Technology (ART) Market Overview
5.3 In-Vitro Fertilization
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 In-Vitro Fertilization: Geographic Segmentation
5.4 Artificial Insemination
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Artificial Insemination: Geographic Segmentation
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation
CHAPTER 6: ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY APPLICATION
6.1 Assisted Reproductive Technology (ART) Market Overview Snapshot and Growth Engine
6.2 Assisted Reproductive Technology (ART) Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Fertility Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Fertility Clinics: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Assisted Reproductive Technology (ART) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Assisted Reproductive Technology (ART) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Assisted Reproductive Technology (ART) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 OVASCIENCE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 IRVINE SCIENTIFIC
7.4 BLOOM IVF CENTRE
7.5 MICROM LTD.
7.6 COOPERSURGICAL INC.
7.7 VITROLIFE
7.8 NIDACON INTERNATIONAL AB
7.9 FERRING B.V.
7.10 LABORATOIRE CCD
7.11 HAMILTON THORNE
CHAPTER 8: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 In-Vitro Fertilization
8.2.2 Artificial Insemination
8.2.3 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Fertility Clinics
8.3.3 Others
CHAPTER 9: NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 In-Vitro Fertilization
9.4.2 Artificial Insemination
9.4.3 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Fertility Clinics
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 In-Vitro Fertilization
10.4.2 Artificial Insemination
10.4.3 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Fertility Clinics
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 In-Vitro Fertilization
11.4.2 Artificial Insemination
11.4.3 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Fertility Clinics
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 In-Vitro Fertilization
12.4.2 Artificial Insemination
12.4.3 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Fertility Clinics
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 In-Vitro Fertilization
13.4.2 Artificial Insemination
13.4.3 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Fertility Clinics
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
CHAPTER 2:EXECUTIVE SUMMARY
CHAPTER 3:GROWTH OPPORTUNITIES BY SEGMENT
3.1 By Type
3.2 By Application
CHAPTER 4: MARKET LANDSCAPE
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
CHAPTER 5: ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TYPE
5.1 Assisted Reproductive Technology (ART) Market Overview Snapshot and Growth Engine
5.2 Assisted Reproductive Technology (ART) Market Overview
5.3 In-Vitro Fertilization
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 In-Vitro Fertilization: Geographic Segmentation
5.4 Artificial Insemination
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Artificial Insemination: Geographic Segmentation
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation
CHAPTER 6: ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY APPLICATION
6.1 Assisted Reproductive Technology (ART) Market Overview Snapshot and Growth Engine
6.2 Assisted Reproductive Technology (ART) Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation
6.4 Fertility Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Fertility Clinics: Geographic Segmentation
6.5 Others
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Others: Geographic Segmentation
CHAPTER 7: COMPANY PROFILES AND COMPETITIVE ANALYSIS
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Assisted Reproductive Technology (ART) Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Assisted Reproductive Technology (ART) Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Assisted Reproductive Technology (ART) Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 OVASCIENCE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 IRVINE SCIENTIFIC
7.4 BLOOM IVF CENTRE
7.5 MICROM LTD.
7.6 COOPERSURGICAL INC.
7.7 VITROLIFE
7.8 NIDACON INTERNATIONAL AB
7.9 FERRING B.V.
7.10 LABORATOIRE CCD
7.11 HAMILTON THORNE
CHAPTER 8: GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 In-Vitro Fertilization
8.2.2 Artificial Insemination
8.2.3 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospitals
8.3.2 Fertility Clinics
8.3.3 Others
CHAPTER 9: NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 In-Vitro Fertilization
9.4.2 Artificial Insemination
9.4.3 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospitals
9.5.2 Fertility Clinics
9.5.3 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
CHAPTER 10: EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 In-Vitro Fertilization
10.4.2 Artificial Insemination
10.4.3 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospitals
10.5.2 Fertility Clinics
10.5.3 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
CHAPTER 11: ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 In-Vitro Fertilization
11.4.2 Artificial Insemination
11.4.3 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospitals
11.5.2 Fertility Clinics
11.5.3 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
CHAPTER 12: MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 In-Vitro Fertilization
12.4.2 Artificial Insemination
12.4.3 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospitals
12.5.2 Fertility Clinics
12.5.3 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
CHAPTER 13: SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET ANALYSIS, INSIGHTS AND FORECAST, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 In-Vitro Fertilization
13.4.2 Artificial Insemination
13.4.3 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospitals
13.5.2 Fertility Clinics
13.5.3 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
CHAPTER 14 INVESTMENT ANALYSIS
CHAPTER 15 ANALYST VIEWPOINT AND CONCLUSION
LIST OF TABLES
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET COMPETITIVE RIVALRY
TABLE 005. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET THREAT OF NEW ENTRANTS
TABLE 006. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET THREAT OF SUBSTITUTES
TABLE 007. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TYPE
TABLE 008. IN-VITRO FERTILIZATION MARKET OVERVIEW (2016-2028)
TABLE 009. ARTIFICIAL INSEMINATION MARKET OVERVIEW (2016-2028)
TABLE 010. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 011. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY APPLICATION
TABLE 012. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 013. FERTILITY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 014. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 017. N ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 020. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 023. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 026. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 029. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 030. OVASCIENCE: SNAPSHOT
TABLE 031. OVASCIENCE: BUSINESS PERFORMANCE
TABLE 032. OVASCIENCE: PRODUCT PORTFOLIO
TABLE 033. OVASCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. IRVINE SCIENTIFIC: SNAPSHOT
TABLE 034. IRVINE SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 035. IRVINE SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 036. IRVINE SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. BLOOM IVF CENTRE: SNAPSHOT
TABLE 037. BLOOM IVF CENTRE: BUSINESS PERFORMANCE
TABLE 038. BLOOM IVF CENTRE: PRODUCT PORTFOLIO
TABLE 039. BLOOM IVF CENTRE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. MICROM LTD.: SNAPSHOT
TABLE 040. MICROM LTD.: BUSINESS PERFORMANCE
TABLE 041. MICROM LTD.: PRODUCT PORTFOLIO
TABLE 042. MICROM LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. COOPERSURGICAL INC.: SNAPSHOT
TABLE 043. COOPERSURGICAL INC.: BUSINESS PERFORMANCE
TABLE 044. COOPERSURGICAL INC.: PRODUCT PORTFOLIO
TABLE 045. COOPERSURGICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. VITROLIFE: SNAPSHOT
TABLE 046. VITROLIFE: BUSINESS PERFORMANCE
TABLE 047. VITROLIFE: PRODUCT PORTFOLIO
TABLE 048. VITROLIFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. NIDACON INTERNATIONAL AB: SNAPSHOT
TABLE 049. NIDACON INTERNATIONAL AB: BUSINESS PERFORMANCE
TABLE 050. NIDACON INTERNATIONAL AB: PRODUCT PORTFOLIO
TABLE 051. NIDACON INTERNATIONAL AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. FERRING B.V.: SNAPSHOT
TABLE 052. FERRING B.V.: BUSINESS PERFORMANCE
TABLE 053. FERRING B.V.: PRODUCT PORTFOLIO
TABLE 054. FERRING B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. LABORATOIRE CCD: SNAPSHOT
TABLE 055. LABORATOIRE CCD: BUSINESS PERFORMANCE
TABLE 056. LABORATOIRE CCD: PRODUCT PORTFOLIO
TABLE 057. LABORATOIRE CCD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. HAMILTON THORNE: SNAPSHOT
TABLE 058. HAMILTON THORNE: BUSINESS PERFORMANCE
TABLE 059. HAMILTON THORNE: PRODUCT PORTFOLIO
TABLE 060. HAMILTON THORNE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 001. EXECUTIVE SUMMARY
TABLE 002. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET COMPETITIVE RIVALRY
TABLE 005. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET THREAT OF NEW ENTRANTS
TABLE 006. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET THREAT OF SUBSTITUTES
TABLE 007. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY TYPE
TABLE 008. IN-VITRO FERTILIZATION MARKET OVERVIEW (2016-2028)
TABLE 009. ARTIFICIAL INSEMINATION MARKET OVERVIEW (2016-2028)
TABLE 010. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 011. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET BY APPLICATION
TABLE 012. HOSPITALS MARKET OVERVIEW (2016-2028)
TABLE 013. FERTILITY CLINICS MARKET OVERVIEW (2016-2028)
TABLE 014. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 015. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 016. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 017. N ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 018. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 019. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 020. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 021. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 022. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 023. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 024. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 025. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 026. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 027. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY TYPE (2016-2028)
TABLE 028. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY APPLICATION (2016-2028)
TABLE 029. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET, BY COUNTRY (2016-2028)
TABLE 030. OVASCIENCE: SNAPSHOT
TABLE 031. OVASCIENCE: BUSINESS PERFORMANCE
TABLE 032. OVASCIENCE: PRODUCT PORTFOLIO
TABLE 033. OVASCIENCE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 033. IRVINE SCIENTIFIC: SNAPSHOT
TABLE 034. IRVINE SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 035. IRVINE SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 036. IRVINE SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. BLOOM IVF CENTRE: SNAPSHOT
TABLE 037. BLOOM IVF CENTRE: BUSINESS PERFORMANCE
TABLE 038. BLOOM IVF CENTRE: PRODUCT PORTFOLIO
TABLE 039. BLOOM IVF CENTRE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. MICROM LTD.: SNAPSHOT
TABLE 040. MICROM LTD.: BUSINESS PERFORMANCE
TABLE 041. MICROM LTD.: PRODUCT PORTFOLIO
TABLE 042. MICROM LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. COOPERSURGICAL INC.: SNAPSHOT
TABLE 043. COOPERSURGICAL INC.: BUSINESS PERFORMANCE
TABLE 044. COOPERSURGICAL INC.: PRODUCT PORTFOLIO
TABLE 045. COOPERSURGICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. VITROLIFE: SNAPSHOT
TABLE 046. VITROLIFE: BUSINESS PERFORMANCE
TABLE 047. VITROLIFE: PRODUCT PORTFOLIO
TABLE 048. VITROLIFE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. NIDACON INTERNATIONAL AB: SNAPSHOT
TABLE 049. NIDACON INTERNATIONAL AB: BUSINESS PERFORMANCE
TABLE 050. NIDACON INTERNATIONAL AB: PRODUCT PORTFOLIO
TABLE 051. NIDACON INTERNATIONAL AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. FERRING B.V.: SNAPSHOT
TABLE 052. FERRING B.V.: BUSINESS PERFORMANCE
TABLE 053. FERRING B.V.: PRODUCT PORTFOLIO
TABLE 054. FERRING B.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. LABORATOIRE CCD: SNAPSHOT
TABLE 055. LABORATOIRE CCD: BUSINESS PERFORMANCE
TABLE 056. LABORATOIRE CCD: PRODUCT PORTFOLIO
TABLE 057. LABORATOIRE CCD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. HAMILTON THORNE: SNAPSHOT
TABLE 058. HAMILTON THORNE: BUSINESS PERFORMANCE
TABLE 059. HAMILTON THORNE: PRODUCT PORTFOLIO
TABLE 060. HAMILTON THORNE: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY TYPE
FIGURE 012. IN-VITRO FERTILIZATION MARKET OVERVIEW (2016-2028)
FIGURE 013. ARTIFICIAL INSEMINATION MARKET OVERVIEW (2016-2028)
FIGURE 014. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 015. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY APPLICATION
FIGURE 016. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 017. FERTILITY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 018. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY TYPE
FIGURE 012. IN-VITRO FERTILIZATION MARKET OVERVIEW (2016-2028)
FIGURE 013. ARTIFICIAL INSEMINATION MARKET OVERVIEW (2016-2028)
FIGURE 014. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 015. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY APPLICATION
FIGURE 016. HOSPITALS MARKET OVERVIEW (2016-2028)
FIGURE 017. FERTILITY CLINICS MARKET OVERVIEW (2016-2028)
FIGURE 018. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 019. NORTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 020. EUROPE ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 021. ASIA PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. SOUTH AMERICA ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET OVERVIEW BY COUNTRY (2016-2028)
